Evidence map›Paper›PMID 41876848›Full record

ArticleBone marrow transplantation2026

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.

Yibo Wu, Lizhen Liu, Yi Chen, Xiaoyu Lai, Yan Chen, Ying Lu, Luxin Yang, Lan Sun, Jiayi He, Fenfang Tong and 9 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yibo Wu *Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0000-0002-5431-1133
Lizhen Liu *Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yi Chen *Department of hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xiaoyu LaiBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yan ChenDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Ying LuDepartment of hematology, the Affiliated People's Hospital of Ningbo University, Ningbo, China.
Luxin YangBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Lan SunDepartment of hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Jiayi HeDepartment of hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Fenfang TongDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Junjie CaoDepartment of hematology, the Affiliated People's Hospital of Ningbo University, Ningbo, China.
Lin LiBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jimin ShiBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yanmin ZhaoBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaolin YuanDepartment of Hematology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.
Panpan ZhuBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
He HuangBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID http://orcid.org/0000-0002-2723-1621
Yajing XuDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Yi LuoBone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. luoyijr@zju.edu.cn.ORCID http://orcid.org/0000-0001-7051-219X

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82170205National Natural Science Foundation of China (National Science Foundation of China) 82300240National Natural Science Foundation of China (National Science Foundation of China) 82470210Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) MS25H080015
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41876848

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.